Ravi Salgia

Ravi Salgia

UNVERIFIED PROFILE

Are you Ravi Salgia?   Register this Author

Register author
Ravi Salgia

Ravi Salgia

Publications by authors named "Ravi Salgia"

Are you Ravi Salgia?   Register this Author

100Publications

2261Reads

36Profile Views

Prolonged Pharmacokinetic Interaction Between Capecitabine and a CYP2C9 Substrate, Celecoxib.

J Clin Pharmacol 2019 Dec 5;59(12):1632-1640. Epub 2019 Jul 5.

Department of Medicine, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.1476DOI Listing
December 2019

USP22 interacts with PALB2 and promotes chemotherapy resistance via homologous recombination of DNA double strand breaks.

Mol Cancer Res 2019 Nov 4. Epub 2019 Nov 4.

Division of Thoracic Surgery, City Of Hope National Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-19-0053DOI Listing
November 2019

Notch signaling in breast cancer: From pathway analysis to therapy.

Cancer Lett 2019 Oct 18;461:123-131. Epub 2019 Jul 18.

Department of Medical Oncology, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA, 91010, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043835193040
Publisher Site
http://dx.doi.org/10.1016/j.canlet.2019.07.012DOI Listing
October 2019

Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer Cells.

J Clin Med 2019 Oct 18;8(10). Epub 2019 Oct 18.

Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8101723DOI Listing
October 2019

Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS.

J Clin Med 2019 Oct 18;8(10). Epub 2019 Oct 18.

Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8101726DOI Listing
October 2019

Early mortality of stage IV non-small cell lung cancer in the United States.

Acta Oncol 2019 Aug 8;58(8):1095-1101. Epub 2019 Apr 8.

f Department of Radiation Oncology , UC Health - Harmony Campus , Fort Collins , CO , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2019.1599138DOI Listing
August 2019

Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice.

Mol Carcinog 2019 08 21;58(8):1438-1449. Epub 2019 Apr 21.

Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.23026DOI Listing
August 2019

The Mitochondrion as an Emerging Therapeutic Target in Cancer.

Trends Mol Med 2019 Jul 18. Epub 2019 Jul 18.

Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2019.06.009DOI Listing
July 2019

Combined Checkpoint Inhibition and Chemotherapy: New Era of 1-Line Treatment for Non-Small-Cell Lung Cancer.

Mol Ther Oncolytics 2019 Jun 19;13:1-6. Epub 2019 Mar 19.

Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte 91010, CA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23727705193000
Publisher Site
http://dx.doi.org/10.1016/j.omto.2019.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444295PMC
June 2019

Targeted Therapies in Non-small-Cell Lung Cancer.

Cancer Treat Res 2019 ;178:3-43

Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-030-16391-4_1DOI Listing
June 2019

RLIP inhibition suppresses breast-to-lung metastasis.

Cancer Lett 2019 Apr 23;447:24-32. Epub 2019 Jan 23.

Department of Medical Oncology, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA, 91010, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043835193004
Publisher Site
http://dx.doi.org/10.1016/j.canlet.2019.01.023DOI Listing
April 2019

RLIP: An existential requirement for breast carcinogenesis.

Biochim Biophys Acta Rev Cancer 2019 04 13;1871(2):281-288. Epub 2019 Feb 13.

Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2019.02.001DOI Listing
April 2019

The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies.

Clin Transl Med 2019 Mar 18;8(1). Epub 2019 Mar 18.

Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Building 51, Room 101, 1500 E Duarte St, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40169-019-0225-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423251PMC
March 2019

2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells.

J Proteomics 2019 02 21;192:233-245. Epub 2018 Sep 21.

Departments of Medical Oncology, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jprot.2018.09.005DOI Listing
February 2019

2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76.

Mol Carcinog 2018 12 19;57(12):1751-1762. Epub 2018 Sep 19.

Department of Medical Oncology, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.22894DOI Listing
December 2018

Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2'-Hydroxyflavanone.

Cancer Lett 2018 12 15;438:144-153. Epub 2018 Sep 15.

Department of Medical Oncology, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA, 91010, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2018.09.015DOI Listing
December 2018

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade.

Clin Transl Med 2018 Oct 8;7(1):32. Epub 2018 Oct 8.

Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Building 51, Room 101, 1500 E Duarte St, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
https://clintransmed.springeropen.com/articles/10.1186/s4016
Publisher Site
http://dx.doi.org/10.1186/s40169-018-0210-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174117PMC
October 2018

Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer.

J Oncol Pract 2018 09 25;14(9):569-571. Epub 2018 Jul 25.

City of Hope Cancer Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00127DOI Listing
September 2018

The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer.

Future Oncol 2018 Aug 16;14(19):1897-1908. Epub 2018 Feb 16.

City of Hope Comprehensive Cancer Center, Department of Medical Oncology & Research Therapeutics, 1500 E Duarte Road, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon-2017-0545
Publisher Site
http://dx.doi.org/10.2217/fon-2017-0545DOI Listing
August 2018

A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2018 08 9;82(2):309-317. Epub 2018 Jun 9.

Section of Hematology Oncology, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3619-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739841PMC
August 2018

Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.

Semin Oncol 2018 08 1;45(4):210-219. Epub 2018 Jul 1.

Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00937754183000
Publisher Site
http://dx.doi.org/10.1053/j.seminoncol.2018.06.002DOI Listing
August 2018

Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma.

Eur Urol 2018 07;74(1):124-128

Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183025
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.03.032DOI Listing
July 2018

Heuristic value-based framework for lung cancer decision-making.

Oncotarget 2018 Jul 6;9(52):29877-29891. Epub 2018 Jul 6.

Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057456PMC
July 2018

Managing Patients With Relapsed Small-Cell Lung Cancer.

J Oncol Pract 2018 06;14(6):359-366

City of Hope National Medical Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00204DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002253PMC
June 2018

Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target.

J Clin Med 2018 Jun 17;7(6). Epub 2018 Jun 17.

Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm7060156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025510PMC
June 2018

Untying the gordion knot of targeting MET in cancer.

Cancer Treat Rev 2018 May 26;66:95-103. Epub 2018 Apr 26.

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372183005
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2018.04.008DOI Listing
May 2018

Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models.

Oncotarget 2018 May 25;9(40):26226-26242. Epub 2018 May 25.

Dana-Farber Cancer Institute, Department of Medical Oncology, Boston 02215, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995226PMC
May 2018

EphB4: A promising target for upper aerodigestive malignancies.

Biochim Biophys Acta Rev Cancer 2018 Apr 31;1869(2):128-137. Epub 2018 Jan 31.

Department of Medicine, Division of Medical Oncology, University of Southern California, Los Angeles, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2018.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955724PMC
April 2018

B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies.

Cell 2018 04 15;173(2):470-484.e18. Epub 2018 Mar 15.

Department of Systems Biology, Beckman Research Institute, and City of Hope Comprehensive Cancer Center, Monrovia, CA 91016, USA; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2018.02.048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284818PMC
April 2018

2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.

Oncotarget 2018 Apr 6;9(26):18053-18068. Epub 2018 Apr 6.

Department of Medical Oncology, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.24720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915057PMC
April 2018

Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients.

Oncotarget 2018 Apr 13;9(28):19793-19806. Epub 2018 Apr 13.

Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.24857DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929426PMC
April 2018

Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy.

BMC Cancer 2018 03 21;18(1):314. Epub 2018 Mar 21.

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center and Beckman Research Institute, 1500 E Duarte Rd, Duarte, CA, 91010-3000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4222-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863467PMC
March 2018

Value-based genomics.

Oncotarget 2018 Mar 30;9(21):15792-15815. Epub 2018 Jan 30.

Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.24353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884665PMC
March 2018

The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer.

Trends Cancer 2018 02 3;4(2):110-118. Epub 2018 Feb 3.

Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2018.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822736PMC
February 2018

Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.

J Immunother Cancer 2018 01 23;6(1). Epub 2018 Jan 23.

Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Building 51, Room 101, 1500 E Duarte St, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-018-0316-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778665PMC
January 2018

Value-Based Medicine and Integration of Tumor Biology.

Am Soc Clin Oncol Educ Book 2017 ;37:833-840

From the Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH; City of Hope Comprehensive Cancer Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175519DOI Listing
November 2017

State-of-the-art considerations in small cell lung cancer brain metastases.

Oncotarget 2017 Sep 18;8(41):71223-71233. Epub 2017 Jul 18.

Department of Medical Oncology and Therapeutics, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19333DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642633PMC
September 2017

Empowering survivors after colorectal and lung cancer treatment: Pilot study of a Self-Management Survivorship Care Planning intervention.

Eur J Oncol Nurs 2017 Aug 19;29:125-134. Epub 2017 Jun 19.

Division of Nursing Research and Education, Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejon.2017.06.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539921PMC
August 2017

Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience.

Oncotarget 2017 Jun;8(26):42198-42213

Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.15030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522060PMC
June 2017

Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer.

Oncol Lett 2017 Jun 29;13(6):4027-4034. Epub 2017 Mar 29.

Department of Medicine, Section of Dermatology, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2017.5956DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452919PMC
June 2017

Genomic mutation-driven metastatic breast cancer therapy: a single center experience.

Oncotarget 2017 04;8(16):26414-26423

Department of Medical Oncology & Molecular Therapeutics, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.14476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432268PMC
April 2017

MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale.

Authors:
Ravi Salgia

Mol Cancer Ther 2017 04;16(4):555-565

City of Hope, Department of Medical Oncology and Therapeutics Research, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0472DOI Listing
April 2017

The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy.

Cancer Treat Rev 2017 Apr 30;55:181-189. Epub 2017 Mar 30.

University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.03.006DOI Listing
April 2017

A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer.

Lung Cancer 2017 03 31;105:7-13. Epub 2016 Dec 31.

Lung Cancer Research Program, Sarah Cannon Research Institute, LLC, Nashville, TN, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.12.020DOI Listing
March 2017

Tumor Heterogeneity and Therapeutic Resistance.

Am Soc Clin Oncol Educ Book 2016 ;35:e585-93

From the Department of Medicine, Department of Cancer Biology, Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN; Department of Internal Medicine, Duke University Medical Center, Durham, NC; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_158808DOI Listing
January 2017

The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.

Sci Signal 2017 01 3;10(460). Epub 2017 Jan 3.

Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, 1111 Highland Avenue, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scisignal.aag1064DOI Listing
January 2017

Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.

Future Oncol 2016 18;12(8):1045-58. Epub 2016 Feb 18.

Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.16.17DOI Listing
December 2016

KRAS in Non-Small-Cell Lung Cancer-Reply.

JAMA Oncol 2016 10;2(10):1373-1374

City of Hope, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.2347DOI Listing
October 2016

Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.

Cancer Lett 2016 10 19;380(2):494-504. Epub 2016 Jul 19.

Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://search.proquest.com/openview/96fc37bbd6ea5af450a03f13
Web Search
http://dx.doi.org/10.1016/j.canlet.2016.07.021DOI Listing
October 2016

MET in the Driver's Seat: Exon 14 Skipping Mutations as Actionable Targets in Lung Cancer.

J Thorac Oncol 2016 09;11(9):1381-3

Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.07.003DOI Listing
September 2016

PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.

Sci Rep 2016 09 13;6:32992. Epub 2016 Sep 13.

Department of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep32992DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021085PMC
September 2016

Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer.

BMC Cancer 2016 08 2;16:568. Epub 2016 Aug 2.

Current address, Department of Medical Oncology and Therapeutics Research, City of Hope, 1500 E Duarte Rd, Duarte, CA, 91010-3000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2636-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969677PMC
August 2016

Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma.

Authors:
Ravi Salgia

Expert Rev Mol Diagn 2016 07 26;16(7):737-49. Epub 2016 May 26.

a Department of Medical Oncology and Therapeutics Research , City of Hope , Duarte , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2016.1181545DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926789PMC
July 2016

Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A Review.

JAMA Oncol 2016 Jun;2(6):805-12

City of Hope Comprehensive Cancer Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.0405DOI Listing
June 2016

FAK and paxillin, two potential targets in pancreatic cancer.

Oncotarget 2016 May;7(21):31586-601

Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/8040
Publisher Site
http://dx.doi.org/10.18632/oncotarget.8040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058780PMC
May 2016

Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.

Cureus 2016 Feb 26;8(2):e513. Epub 2016 Feb 26.

Medical Oncology and Therapeutics Research, City of Hope.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807912PMC
February 2016

ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy.

J Clin Neurosci 2015 Dec 7;22(12):1978-9. Epub 2015 Jul 7.

Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2015.04.009DOI Listing
December 2015

Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.

J Clin Oncol 2015 Dec 2;33(36):4284-92. Epub 2015 Nov 2.

Daniel V.T. Catenacci, Theodore Karrison, James Wallace, Mark Kozloff, Peng Xu, Les Henderson, Ravi Salgia, Walter M. Stadler, Hedy L. Kindler, University of Chicago Medical Center; Patrick Stiff, Loyola University Medical Center, Chicago; Robert Marsh, Northshore University Health System, Evanston; James Wallace, Mark Kozloff, Ingalls Hospital, Harvey; James Wade, Decatur Memorial Hospital, Decatur; Pankaj Kumar, Oncology/Hematology Associates, Peoria, IL; Melissa R. Junttila, Xi Wang, and Frederic J. de Sauvage, Genentech, South San Francisco; Heinz-Josef Lenz, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA; Nathan Bahary, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Margit N. Horiba, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Sreenivasa R. Nattam, Ft Wayne Medical Oncology/Hematology, Ft Wayne, IN; Lakshmi Rajdev, Montefiore Medical Center, Bronx; Deirdre Cohen, New York University Cancer Center, New York, NY; Bethany Sleckman, St John's Mercy Medical Center, St Louis, MO; and Naoko Takebe, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.8719DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678179PMC
December 2015

Lung cancer-a fractal viewpoint.

Nat Rev Clin Oncol 2015 Nov 14;12(11):664-75. Epub 2015 Jul 14.

Section of Hematology/Oncology, University of Chicago, 5841 South Maryland Avenue, MC 2115 Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2015.108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989864PMC
November 2015

Whole-animal mounts of Caenorhabditis elegans for 3D imaging using atomic force microscopy.

Nanomedicine 2015 Nov 15;11(8):1971-4. Epub 2015 Aug 15.

Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051269PMC
http://dx.doi.org/10.1016/j.nano.2015.07.014DOI Listing
November 2015

HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.

Front Oncol 2015 21;5:164. Epub 2015 Jul 21.

Section of Pulmonary and Critical Care, Department of Medicine, Pritzker School of Medicine, The University of Chicago , Chicago, IL , USA ; Department of Anesthesia and Critical Care, Pritzker School of Medicine, The University of Chicago , Chicago, IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2015.00164DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508840PMC
August 2015

MET as a drug target.

Authors:
Ravi Salgia

Clin Adv Hematol Oncol 2015 Jun;13(6):351-3

Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
June 2015